Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology - 1 Jul 2014

Bourgeois N, Laurens C, Bertout S, Balard Y, Krasteva D, Rispail P, Lachaud L

Abstract excerpt

Candida glabrata has emerged as a major pathogen in invasive candidiasis in recent years. Currently, guidelines for invasive candidiasis treatment recommend fluconazole or an echinocandin as the first-line therapy. Nevertheless, the resistance of Candida glabrata to echinocandin is an emerging problem and has been partly associated with mutations in the FKS1 and FKS2 genes. The Etest® is an appropriate method for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Candida glabrata
Share to Caspofungin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Echinocandins

Share to Fungal Proteins

Share to Genotyping Techniques

Share to Lipopeptides

Share to Microbial Sensitivity Tests

Share to Mutation

Source

Identifiers

PMID: 24522619
DOI: 10.1007/s10096-014-2069-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations.PMID 24522619Read ↗

Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.Semantic proximity Read ↗

Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).Semantic proximity Read ↗

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.Semantic proximity Read ↗

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Semantic proximity Read ↗

Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.Semantic proximity Read ↗

Clinical perspectives on echinocandin resistance among Candida species.Semantic proximity Read ↗

Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.Semantic proximity Read ↗

Set of Classical PCRs for Detection of Mutations in <i>Candida glabrata FKS</i> Genes Linked with Echinocandin ResistanceSemantic proximity Read ↗

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.Semantic proximity Read ↗

The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.Semantic proximity Read ↗

Emergence of resistantCandida glabratain GermanySemantic proximity Read ↗

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.